Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-May-22 5:14 PM View:  | Phasebio Pharmaceuticals Inc (PHAS) | 23-May-22 | Sale (Planned) | 11,248 | $0.79 | $8,885.92 | (100%) 11.25K to 0 | |
| 24-May-22 5:14 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-22 | Grant | 11,248 | $0.68 | $7,663.26 | 100% 0 to 11.25K | |
| 23-Nov-21 6:50 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-Nov-21 | Grant | 5,766 | $2.01 | $11,589.70 | 100% 0 to 5.77K | |
| 23-Nov-21 6:50 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-Nov-21 | Market Sale (Planned) | 5,766 | $2.37 | $13,665.40 | (100%) 5.77K to 0 | |
| 24-May-21 6:11 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-21 | Grant | 3,811 | $2.80 | $10,670.80 | 100% 0 to 3.81K | |
| 24-May-21 6:11 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-21 | Market Sale | 3,811 | $3.29 | $12,538.20 | (100%) 3.81K to 0 | |
| 23-Nov-20 6:27 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 23-Nov-20 | Market Sale | 3,497 | $3.45 | $12,064.70 | (100%) 3.5K to 0 | (4%) |
| 23-Nov-20 6:27 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-Nov-20 | Grant | 3,497 | $3.00 | $10,491.00 | 100% 0 to 3.5K |